Showing results (121-130 of 206) with videos related to

Sort By:
Pageof 21
Haematologica|May 30, 2013
Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasmsCristina Pérez, Marien Pascual, José Ignacio Martín-Subero, et al.
Journal of Clinical Laboratory Analysis|December 20, 2023
High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndromeGonzalo Blanco, Daniel López-Aventín, Ramon M Pujol, et al.
Blood|May 29, 2010
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemiaAlberto Alvarez-Larrán, Francisco Cervantes, Arturo Pereira, et al.
The American Journal of Surgical Pathology|September 27, 2006
Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic studyAntonio Salar, Nuria Juanpere, Beatriz Bellosillo, et al.
Clinical Lung Cancer|March 23, 2019
Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive PatternsSergi Clavé, Natalia Rodon, Lara Pijuan, et al.
Leukemia & Lymphoma|September 22, 2012
Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?Anna Puiggros, Eulàlia Puigdecanet, Marta Salido, et al.
Genome Biology|November 23, 2020
The evolution of relapse of adult T cell acute lymphoblastic leukemiaInés Sentís, Santiago Gonzalez, Eulalia Genescà, et al.
The Journal of Investigative Dermatology|August 25, 2015
Notch1 Pathway Activation Results from the Epigenetic Abrogation of Notch-Related MicroRNAs in Mycosis FungoidesFernando Gallardo, Juan Sandoval, Angel Díaz-Lagares, et al.
Blood Advances|April 12, 2022
Sézary syndrome patient-derived models allow drug selection for personalized therapyFernando Gallardo, Evelyn Andrades, Arnau Iglesias, et al.
Haematologica|January 19, 2019
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulatedNicolás Martínez-Calle, Marien Pascual, Raquel Ordoñez, et al.
Pageof 21